Shaolei Lu

Also affiliated with Rhode Island Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study”.

Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1548

N/A

0DataRank · unranked

56 citations

Fadi Shehadeh, Evangelia K. Mylona, Josiah D. Rich, Marguerite A. Neill, Francine Touzard-Romo +7 more

Prognostication of patients with COVID-19 using artificial intelligence based on chest x-rays and clinical data: a retrospective study

The Lancet Digital Health(2021)10.1016/s2589-7500(21)00039-x

N/A

0DataRank · unranked

126 citations

Ji Whae Choi, Kasey Halsey, Thi My Linh Tran, B. R. Hsieh, Dongcui Wang +20 more

GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer

International Journal of Molecular Sciences(2023)10.3390/ijms241310870

N/A

0DataRank · unranked

25 citations

Anna D. Louie, Praveen R. Srinivasan, Christoph Schorl, Shaolei Lu, David Silverberg +9 more

Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase

Cancer Letters(2023)10.1016/j.canlet.2023.216493

N/A

0DataRank · unranked

5 citations

Xuewei Bai, Dan Liú, Kevin Cao, Joud Mulla, Chengcheng Ji +12 more

GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.07.527499

N/A

0DataRank · unranked

6 citations

Anna D. Louie, Praveen R. Srinivasan, Christoph Schorl, Shaolei Lu, David Silverberg +9 more

GSK-3 inhibitor elraglusib (9-ING-41) to enhance tumor-infiltrating immune cell activation in tumor biopsies and synergize with anti-PD-L1 in a murine model of colorectal cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e15138

N/A

0DataRank · unranked

1 citations

Kelsey E. Huntington, Anna D. Louie, Praveen Srinivasan, Cristoph Schorl, Shaolei Lu +10 more

Targeting PKCα alleviates iron overload in diabetes and hemochromatosis through the inhibition of ferroportin

Blood(2024)10.1182/blood.2024023829

N/A

0DataRank · unranked

13 citations

Shaolei Lu, Anand Jain, Irène Wang, Hui Tao, Shanthi Srinivasan +3 more

Genetic disruption of mitochondrial dynamics and stasis leads to liver injury and tumorigenesis

Journal of Clinical Investigation(2025)10.1172/jci194441

N/A

0DataRank · unranked

3 citations

Xiaoli Wei, Mengwei Niu, Chen Zhang, Zheyun Peng, Wanqing Liu +10 more

The Complexity of SIRT2 in Chronic Liver Disease: Liver SIRT2 Promotes Hepatocellular Carcinoma Development

Cellular and Molecular Gastroenterology and Hepatology(2025)10.1016/j.jcmgh.2025.101512

N/A

0DataRank · unranked

1 citations

Shaolei Lu, Chiung‐Kuei Huang, Xinjian Li